Top experts in tumor biology and precision cancer medicine to present at WIN 2014 Symposium
Posted: Tuesday, September 24, 2013
Robert Weinberg, Leroy Hood, Bob Löwenberg, Olli Kallioniemi, Rene Bernards, Guido Kroemer, Hans Clevers, Matthias Uhlen and Other Top Experts in Tumor Biology and Precision Cancer Medicine to Present at WIN 2014 Symposium
The world’s leaders in tumor biology and precision cancer medicine will present keynote lectures in an exceptional event entirely dedicated to combination therapies for cancer under the title:
WINning combinations for precision cancer medicine: Breakthrough molecular investigations and combined therapeutic approaches
About WIN Consortium
The WIN Consortium is a not-for-profit global collaboration of leading academic, industry, health plan, and advocacy organizations that runs global research projects identifying biomarkers for targeted therapies and clinical trials investigating targeted cancer treatments. WIN’s mission is to accelerate the pace and reduce the cost of translating the most promising innovations in personalized cancer medicine into the standard of care worldwide.
Contacts
For further information about the WIN2014 Symposium contact:
WIN 2014 Symposium Secretariat
Congress by design
win@congressbydesign.com
Tel. +31 88 089 8101
(or)
For further information about the WIN Consortium contact:
Catherine Bresson
Director, Operational Team
Catherine.Bresson@winconsortium.org